Morningstar

CVS Health Up Over 7%, on Track for Highest Close Since February 2023 — Data Talk

Provided by Dow Jones

CVS Health Corporation (CVS) is currently at $86.60, up $5.92 or 7.33% 




       --Would be highest close since Feb. 23, 2023, when it closed at $86.87 



       --On pace for largest percent increase since Feb. 12, 2025, when it rose 14.95% 



       --Snaps a four day losing streak 



       --Up 9.13% year-to-date 



       --Down 23.66% from its all-time closing high of $113.45 on July 29, 2015 



       --Up 29.69% from 52 weeks ago (May 7, 2025), when it closed at $66.78 



       --Would be a new 52-week closing high 



       --Up 47.41% from its 52-week closing low of $58.75 on July 24, 2025 



       --Traded as high as $88.63; highest intraday level since Feb. 17, 2023, when it hit $88.75 



       --Up 9.84% at today's intraday high; largest intraday percent increase since April 8, 2025, when it rose as much as 11.9% 





     All data as of 10:42:52 AM ET 





     Source: Dow Jones Market Data, FactSet 





  (END) Dow Jones Newswires



  May 06, 2026 11:00 ET (15:00 GMT)


Copyright (c) 2026 Dow Jones & Company, Inc.
  

					The articles, information, and content displayed on this webpage may
					include materials prepared and provided by third parties. Such
					third-party content is offered for informational purposes only and
					is not endorsed, reviewed, or verified by Morningstar.
				
 

					Morningstar makes no representations or warranties regarding the
					accuracy, completeness, timeliness, or reliability of any third-party
					content displayed on this site. The views and opinions expressed in
					third-party content are those of the respective authors and do not
					necessarily reflect the views of Morningstar, its affiliates, or employees.
				
 

					Morningstar is not responsible for any errors, omissions, or delays
					in this content, nor for any actions taken in reliance thereon.
					Users are advised to exercise their own judgment and seek independent
					financial advice before making any decisions based on such content.
					The third-party providers of this content are not affiliated with
					Morningstar, and their inclusion on this site does not imply any
					form of partnership, agency, or endorsement.
				
 

				Popular
				
 
  
 
 
 
 
3 Stocks to Sell and 3 Stocks to Buy for October
 
Plus, lessons from September’s stock market activity. 
 
 
David Sekera, CFA and Susan Dziubinski 
 
 
 
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
 
With a 3.3% dividend yield and earnings growth expected to exceed management’s outlook, this 4-star stock stands out in a struggling sector. 
 
 
Andrew Bischof, CFA, CPA 
 
 
 
The Thrilling 37
 
Just a few strict screens can narrow the field to an elite group of funds. 
 
 
Russel Kinnel 
 
 
 
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
 
Ask the Analyst columnist Amy Arnott answers a grab bag of reader questions about bond ETFs, TIPS, retirement planning, and more. 
 
 
Amy C. Arnott, CFA and Ivanna Hampton 
 
 
 
3 Stocks to Invest In With More Room to Run
 
These stocks are up significantly in 2026, yet still look undervalued today. 
 
 
Susan Dziubinski 
 
 
 
 

			Sponsor Center